Minor
DELTA CARE 1 · 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream · Lichen Sclerosus
Trial sites expanded: 25 → 33 locations
LEO PharmaPhase 3 NCT07335588 Registry history of NCT07335588 on ClinicalTrials.gov (opens the registry)
Updated